You are viewing the site in preview mode
Skip to main content
|
Clinical, HHT-related (n = 9a)
|
|
Epistaxis, n (%)
|
9 (100)
|
|
Visceral AVMs, n (%)
|
2 (22.2)
|
|
Epistaxis Worsening, n (%)
|
3 (33.3)
|
|
Epistaxis Unchanged, n (%)
|
6 (66.7)
|
|
Epistaxis Improvement, n (%)
|
0
|
|
Increased bleeding from oral telangiectases, n (%)
|
0
|
|
Chronic Anemia
|
|
Hb deficit level (n = 6a)
| |
|
Mild, n
|
5
|
|
Intermediate, n
|
1
|
|
Severe, n
|
0
|
|
Very Severe, n
|
0
|
|
Iron replacement therapy (n = 8a)
| |
|
Oral Supplementation, n
|
3
|
|
IV Injection, n
|
2
|
|
Blood Transfusion, n
|
0
|
- AVMs = Arterio-Venous Malformations; Hb level deficit: Mild (Hb > 12 gr/dl), Intermediate (10–12 gr/dl), Severe 7–10 gr/dl), Very Severe (< 7 gr/dl); aNumber of respondents for each variable
